Connect
MJA

Antidepressant‐induced sexual dysfunction

Jody Rothmore
Med J Aust 2020; 212 (7): . || doi: 10.5694/mja2.50522
Published online: 16 March 2020

Summary

  • Sexual dysfunction is a frequent, potentially distressing, adverse effect of antidepressants and a leading cause of medication non‐adherence.
  • Sexual function should be actively assessed at baseline, at regular intervals during treatment, and after treatment cessation.
  • Trials comparing the risk of sexual dysfunction with individual antidepressants are inadequate, but it is reasonable to conclude that the risk is greatest with selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs), less with tricyclic antidepressants (except clomipramine) and mirtazapine, and least with moclobemide, agomelatine, reboxetine and bupropion.
  • Management of antidepressant‐induced sexual dysfunction requires an individualised approach (eg, considering other causes, dose reduction, addition of medication to treat the adverse effect, switching to a different antidepressant).
  • Post‐SSRI sexual dysfunction has been recently identified as a potential, although rare, adverse effect of SSRIs and SNRIs. Consider the possibility of post‐SSRI sexual dysfunction in patients in whom sexual dysfunction was absent before starting antidepressants but develops during or soon after antidepressant treatment and still persists after remission from depression and discontinuation of the drug.
  • Jody Rothmore

  • Drug and Therapeutics Information Service, Southern Adelaide Local Health Network, Adelaide, SA

Correspondence: jody.rothmore@sa.gov.au

Acknowledgements: 

I thank Tarryn Cowain, David Coyte, Joy Gailer, Tania Colarco, Lauren Wierenga, Rosemary Allin and Susan Edwards for reading and editing the manuscript and providing some helpful comments.

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.